5.4 Systemic Hypertension & Hypertensive Heart Disease in Children

5.4 Systemic Hypertension & Hypertensive Heart Disease in Children

Clinical Core: Systemic hypertension appears on the ARDMS Pediatric Echocardiography content outline as its own Acquired Heart Disease task (2.A.3), and it is tested from the sonographer's vantage point: the echocardiogram does not diagnose hypertension, it grades the damage hypertension has already done and hunts for a correctable cardiovascular cause. Roughly 3% to 4% of American children meet criteria for hypertension, and the prevalence rises steeply with obesity. Unlike the adult laboratory, a pediatric laboratory must treat every newly hypertensive child as a potential coarctation until the arch has been cleared.

---

Defining Hypertension in Children: The 2017 AAP Framework

Pediatric blood pressure thresholds are age, sex, and height dependent below age 13 because normal pressure rises with somatic growth. The 2017 American Academy of Pediatrics Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents replaced the older 2004 tables and removed overweight and obese children from the normative dataset, which lowered every percentile cut point.

Three separate elevated office readings are required before the diagnosis is confirmed, and 24-hour ambulatory blood pressure monitoring is the reference standard used to separate true hypertension from white-coat hypertension and to identify masked hypertension in children with chronic kidney disease or repaired coarctation.

---

Primary Versus Secondary Hypertension: Why Age Matters

The younger and the more severely hypertensive the child, the more likely the cause is secondary and structural.

• Infants and young children: overwhelmingly secondary. Renal parenchymal disease (reflux nephropathy, glomerulonephritis, polycystic kidney disease), renovascular disease (fibromuscular dysplasia, neurofibromatosis type 1, mid-aortic syndrome), coarctation of the aorta, umbilical artery catheter-related renal artery thrombosis in the neonate, and endocrine causes (congenital adrenal hyperplasia, pheochromocytoma, hyperthyroidism).
• Adolescents: primary (essential) hypertension predominates, tracking with obesity, obstructive sleep apnea, sodium intake, stimulant medications, oral contraceptives, and anabolic or energy-drink use.

The Mandatory Coarctation Exclusion Protocol

Missing a coarctation in a hypertensive child is one of the most consequential errors a pediatric sonographer can make, because it converts a lifelong pharmacologic problem into a curable one. Every study on a hypertensive child must include:

1. Suprasternal notch long-axis sweep of the transverse arch and isthmus with two-dimensional and color Doppler, plus a high left parasternal ductal cut in infants.
2. Continuous-wave Doppler at the isthmus looking for a high-velocity systolic jet with diastolic tailing (antegrade diastolic runoff), the hallmark that separates true obstruction from a simple velocity step-up.
3. Pulsed-wave Doppler in the abdominal aorta from the subcostal window. A normal abdominal aortic waveform is sharply pulsatile with an early systolic peak, a brisk downstroke, and zero or reversed diastolic flow. Coarctation produces a damped, low-amplitude waveform with a slurred upstroke and continuous antegrade diastolic flow.
4. Four-limb blood pressures, with a right arm to leg systolic gradient above 20 mmHg treated as positive. The right arm is chosen because an aberrant right subclavian artery or a coarctation proximal to the left subclavian can falsely equalize the left arm pressure.
5. Assessment of the bicuspid aortic valve and the ascending aorta, since roughly half to two-thirds of coarctation patients have a bicuspid valve.

---

Quantifying Target-Organ Damage: Left Ventricular Mass

The AAP guideline positions echocardiography as the tool for target-organ damage assessment, recommending a study at the time pharmacologic therapy is considered and repeat imaging at approximately 6 to 12 month intervals while hypertrophy persists or blood pressure remains uncontrolled.

The Devereux Formula and Height^2.7 Indexing

Left ventricular mass is derived from linear end-diastolic measurements of the septum, cavity, and posterior wall, obtained from a two-dimensionally guided parasternal long-axis M-mode or from direct two-dimensional linear calipers perpendicular to the long axis at the mitral leaflet tip level:

LV mass (g) = 0.8 x [1.04 x ((LVIDd + PWTd + SWTd)^3 - LVIDd^3)] + 0.6

In children, mass is not indexed to body surface area, because BSA indexing normalizes away the very obesity that drives adolescent hypertension and systematically hides hypertrophy in heavy children. Pediatric practice indexes instead to height raised to the 2.7 power (g/m^2.7), an allometric exponent that keeps the index essentially flat across normal childhood growth.

The Four Hypertensive Geometries

Relative wall thickness (RWT) = 2 x PWTd / LVIDd. Combining RWT with mass index yields the four patterns the exam expects the sonographer to name:

Measurement discipline matters enormously here. Because the cavity and wall dimensions are cubed in the Devereux formula, a 1 mm caliper error on a small child's 8 mm posterior wall translates into a mass error far larger than 12%. Always measure at true end-diastole (onset of the QRS), exclude right ventricular trabeculations and the moderator band from the septum, exclude the papillary muscles and pericardium from the posterior wall, and keep the beam perpendicular to the long axis to avoid the oblique over-measurement that plagues foreshortened parasternal images.

---

Functional Consequences: Diastole and Strain Fail First

Hypertensive pediatric hearts almost never present with a low ejection fraction. The abnormalities appear in this order:

1. Reduced global longitudinal strain (GLS). Subendocardial longitudinal fibers are the most pressure-sensitive layer; speckle-tracking GLS becomes less negative while ejection fraction and fractional shortening remain squarely normal.
2. Impaired relaxation. Mitral annular tissue Doppler e' velocity falls, the mitral inflow E/A ratio drops toward or below 1, and isovolumic relaxation time lengthens.
3. Elevated filling pressures. The E/e' ratio rises, left atrial volume index increases, and the pulmonary venous atrial reversal (Ar) wave lengthens and deepens.
4. Late systolic decline. Only after years of uncontrolled pressure does ejection fraction fall.

A useful pediatric caveat: E/e' cut points borrowed from adults do not transfer cleanly to children, because e' velocities are physiologically high in normal children and fall with age. Report the value against a pediatric nomogram and in the trend context of prior studies rather than against a single adult threshold.

Associated Findings to Report

• Aortic root and ascending aortic dimensions with Z-scores — chronic hypertension accelerates aortic dilation, and in adolescents it may unmask an unsuspected aortopathy.
• Left atrial volume index — a durable integrator of chronically elevated filling pressure.
• Aortic and mitral regurgitation severity — afterload-sensitive lesions that worsen with pressure load.
• Coronary origins — routinely imaged in any pediatric study, and specifically relevant if the child has neurofibromatosis or Williams syndrome as a hypertension substrate.

---

Exam-Day Traps

• Cuff artifact. An undersized cuff falsely elevates pressure. The bladder should encircle 80% to 100% of the arm circumference and cover 40% of the arm width. Never chase an echocardiographic diagnosis for a pressure recorded with the wrong cuff.
• Mistaking physiologic athletic remodeling for hypertensive hypertrophy. A trained adolescent athlete shows increased mass with a normal or low relative wall thickness, normal or supernormal e', and normal GLS; hypertensive hypertrophy concentrates wall thickness and degrades e' and GLS.
• Anchoring on the left ventricle. Renal, renovascular, and mid-aortic causes require the abdominal aortic Doppler interrogation described above; the sonographer who images only the heart in a hypertensive child has performed half the study.
• Forgetting the neonate. In a hypertensive neonate with a prior umbilical arterial catheter, interrogate the abdominal aorta and renal artery origins for catheter-related thrombus.